Comparison of the effects of chronic oral therapy with atenolol and sotalol on ventricular monophasic action potential duration and effective refractory period

American Heart Journal
B P WayS M Cobbe


The effects of 4 weeks' therapy with atenolol, 50 mg twice daily, and sotalol, 160 mg twice daily, on ventricular monophasic action potential duration (MAPD90) and effective refractory period (VERP) are compared in a randomized cross-over study in 10 patients with stable angina pectoris undergoing elective cardiac catheterization. At matched ventricular pacing cycle lengths (range 500 to 1000 msec), MAPD90 was 29 to 42 msec (11.5% to 13.4%) longer and VERP was 21 to 32 msec (8.9% to 11.4%) longer on oral sotalol than on oral atenolol. Intravenous sotalol (100 mg) caused a significant lengthening of MAPD90 and VERP during oral atenolol therapy, while intravenous atenolol (10 mg) had no additional effect during oral sotalol therapy. The effects of sotalol on ventricular repolarization and refractory period persist over and above any adaptational response to beta-receptor blockade that may occur during chronic therapy.


Jun 1, 1991·Clinical Cardiology·E PattersonR Lazzara
Feb 19, 2002·British Journal of Clinical Pharmacology·Michael J AllenDonald J Nichols
Mar 1, 1995·Pacing and Clinical Electrophysiology : PACE·J P Claudel, P Touboul
Nov 1, 1990·Pharmacology & Toxicology·E MortensenH Refsum
Sep 1, 1991·British Heart Journal·N J LinkerD E Ward
Apr 1, 1992·American Heart Journal·E MortensenH Refsum
Aug 12, 1993·The American Journal of Cardiology·R W Campbell, S S Furniss
Nov 15, 2011·British Journal of Pharmacology·Herbert M HimmelErich Wettwer
Feb 1, 1993·Journal of Cardiovascular Electrophysiology·R Ruffy

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.